Citi Reaffirms Their Hold Rating on Nestlé SA (NSRGF)
Don't Miss TipRanks' Half Year Sale
Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Besnard covers the Consumer Defensive sector, focusing on stocks such as DANONE SA, Nestlé SA, and Tate & Lyle. According to TipRanks, Besnard has an average return of 1.0% and a 52.94% success rate on recommended stocks.
In addition to Citi, Nestlé SA also received a Hold from Exane BNP Paribas's Jeff Stent in a report issued on June 27. However, on the same day, Jefferies maintained a Sell rating on Nestlé SA (Other OTC: NSRGF).
NSRGF market cap is currently $247.8B and has a P/E ratio of 20.90.
Based on the recent corporate insider activity of 10 insiders, corporate insider sentiment is neutral on the stock.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
7 hours ago
- Business Insider
Citi Remains a Buy on Genius Sports Limited (GENI)
Citi analyst Jason Bazinet maintained a Buy rating on Genius Sports Limited today and set a price target of $16.00. The company's shares closed today at $12.52. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Bazinet is a 5-star analyst with an average return of 16.4% and a 63.15% success rate. Bazinet covers the Communication Services sector, focusing on stocks such as Electronic Arts, Walt Disney, and Netflix. In addition to Citi, Genius Sports Limited also received a Buy from Financial's Josh Nichols in a report issued on August 7. However, on August 6, TR | OpenAI – 4o downgraded Genius Sports Limited (NYSE: GENI) to a Hold. Based on Genius Sports Limited's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $143.99 million and a GAAP net loss of $8.2 million. In comparison, last year the company earned a revenue of $119.72 million and had a GAAP net loss of $25.54 million Based on the recent corporate insider activity of 20 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of GENI in relation to earlier this year.
Business Upturn
10 hours ago
- Business Upturn
Pharma sector stocks in focus: Citi flags competitive setback for Dr Reddy's, Aurobindo in iron sucrose opportunity
By Arunika Jain Published on August 12, 2025, 08:33 IST Citi has highlighted a potential setback for Indian generic drugmakers Dr Reddy's Laboratories and Aurobindo Pharma after the USFDA approved two generic versions of Iron Sucrose, developed by Viatris and Amphastar. Both companies may be eligible for 180 days of Competitive Generic Therapy (CGT) exclusivity. The brokerage noted that no Indian pharmaceutical companies have yet announced approvals for this product. Given Iron Sucrose was considered an important pipeline opportunity for Dr Reddy's and Aurobindo, Citi believes the latest development — with competitors moving ahead — suggests this could now be a reduced or lost opportunity for them. Citi added that it would wait to see if more companies announce approvals before reassessing the competitive landscape for the product. Disclaimer: The above views are those of Citi. This update is for news reporting purposes only and does not constitute investment advice. Ahmedabad Plane Crash Arunika Jain, a graduate in Mass Communication, brings a fresh perspective to the world of journalism. Arunika has a passion for writing finance and corporate news at You can write to her at [email protected]
Bloomberg
14 hours ago
- Bloomberg
Stock Rally Stalls Ahead of CPI Inflation Report
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are UBS Global Wealth Management's Brenda O'Connor Juanas, Seaport Research Partners' David Joyce, DVx Ventures' Jon McNeil, Ameriprise Financial's Anthony Saglimbene, Citi's Kristen Bitterly, KPMG's Diane Swonk, Seaport Research Partners' Jay Goldberg, Veda Partners' Henrietta Treyz. (Source: Bloomberg)
